Cleanascite™ Lipid Removal Reagent and Clarification
Cleanascite™ Lipid Removal Reagent and Clarification
- A high binding capacity for lipids with minimal cross-reactivity with proteins
- Effectively replaces chlorinated/fluorinated hydrocarbons (eg. freon) and it is environmentally friendly.
- Helps purify antibodies, recombinant proteins, nucleic acids, proteoglycans
- Ideal for clarifying ascites, serum, cell & tissue culture, bile and organ homogenates
- Clarifies saliva and fecal components
- Very low protein binding
- Does not bind to DNA, RNA, enzymes and proteins
- Leaves glycoproteins, antibodies, nucleic acids, hemoglobin, proteoglycans, nucleic acids, serum components(such as hormones, nutrients, globulins, clotting factors, transport proteins) alone
- Extends the life of membrane and chromatographic columns.
- Enrichment of delipidated tissue samples
- Ideal for delipidation treatments for downstream processing of large-scale therapeutic proteins, enzymes and monclonal antibodies.
Cleanascite™ selectively removes lipids, cell debris, lipoproteins, floating fats, impurities from cohn paste, transgenic milk, egg yolk and biological samples for pretreatment of samples prior to purification. The reagent is a solid-phase, non-ionic adsorbent supplied as a suspension in saline, ready for use. Simply add, centrifuge and/or filter. The clarified supernatant is ready for subsequent downstream processing or analysis.
Click here to view Cleanascite™ Product Sheet
Thrombin-inhibiting perfluorocarbon nanoparticles provide a novel strategy for treatment and magnetic resonance imaging of acute thrombosis Journal of Thrombosis and Haemostasis J. Myerson, L. He et al 2011.
Red blood cells release factors with growth and survival bioactivities for normal and leukemic T cells Immunology and Cell Biology (2011) 89, 111–121
Dujuan Li, Jianping Wang, Ronghui Wang, Yanbin Li, Daad Abi-Ghanem, Luc Berghman, Billy Hargis, Huaguang Lu, A nanobeads amplified QCM immunosensor for the detection of avian influenza virus H5N1, Biosensors and Bioelectronics, Volume 26, Issue 10, 15 June 2011, Pages 4146-4154
Analysis conditions for proteomic profiling of mammalian tissue and cell extracts with antibody microarrays. Alhamdani MS, Schröder C, Hoheisel JD, Division of Functional Genome Analysis, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany. Proteomics. 2010 Sep;10(17):3203-7
R. Kenneth Czambel, Alexander Kharlamov, Stephen C. Jones, Variations of brain endothelial nitric oxide synthase concentration in rat and mouse cortex, Nitric Oxide, Volume 22, Issue 1, 1 January 2010, Pages 51-57
Michal Lijowski, Shelton Caruthers et al High-Resolution SPECT-CT/MR Molecular Imaging of Angiogenesis in the Vx2 Model Invest Radiol. Invest Radiol. 2009 January; 44(1): 15–22
Dwipendra Thakuria et al Field preservation and DNA extraction methods for intestinal microbial diversity analysis in earthwormsJournal of Microbiological Methods Volume 76, Issue 3, March 2009, Pages 226-233
Annarita Farina, Jean-Marc Dumonceau et al. Proteomic Analysis of Human Bile from Malignant Biliary Stenosis Induced by Pancreatic Cancer Journal of Proteome Research 2009 8 (1), 159-169
Joseph D. Turner J. Wolbachia Lipoprotein Stimulates Innate and Adaptive Immunity through Toll-like Receptors 2 and 6 to Induce Disease Manifestations of Filariasis Biol. Chem. 2009 284: 22364-22378.
Jordi B Torrelles, Lucy E DesJardin, et al, Inactivation of Mycobacterium tuberculosis mannosyltransferase pimB reduces the cell wall lipoarabinomannan and lipomannan content and increases the rate of bacterial-induced human macrophage cell death Glycobiology (2009) 19(7): 743-755
Garton NJ, Waddell SJ, Sherratt AL, Lee S-M, Smith RJ, et al. 2008 Cytological and Transcript Analyses Reveal Fat and Lazy Persister-Like Bacilli in Tuberculous Sputum. PLoS Med 5(4): e75
Contribution of solid-phase hexapeptide ligand libraries to the repertoire of human bile proteins: Journal of Chromatography A Volume 1176, Issues 1-2, 28 December 2007, Pages 192-205
L. Guerrier, S. Claverol, L. Finzi Two-dimensional electrophoresis for comparative proteomic analysis of human bile Bo Chen, et al Hepatobiliary Pancreat Dis Int，Vol 6，No 4 August 2007
Establishment and preliminary analysis of a 2-D human biliary map CHEN Bo et al Chinese Journal of Hepatobiliary 2007
Li M. Fu and Thomas M. Shinnick Genome-wide exploration of the drug action of capreomycin on Mycobacterium tuberculosis using Affymetrix oligonucleotide GeneChips Journal of Infection Volume 54, Issue 3, March 2007, Pages 277-284
Genome-wide analysis of intergenic regions of mycobacterium tuberculosis H37Rv using affymetrix genechips. EURASIP J. Bioinformatics Syst. Biol. 2007 (January 2007)
Castro, Arnold R., Morrill, William E., Pope, Victoria Lipid Removal from Human Serum Samples Clin. Diagn. Lab. Immunol. 2000 7: 197-199
Chen B, Dong JQ, Chen YJ, Wang JM Two-dimensional electrophoresis for comparative proteomic analysis of human bile. Hepatobiliary Pancreat Dis Int. 2007 Aug;6(4):402-6
L. Guerrier et al Contribution of solid-phase hexapeptide ligand libraries to the repertoire of human bile proteins Journal of Chromatography A Volume 1176, Issues 1-2, 28 December 2007, Pages 192-205
Aaron M. Cheng, Ernest E. Moore, Tomohiko Masuno, Guillermo A. Escobar, Eric L. Sarin, Jeffrey L. Johnson, Phillip Eckels, Anirban Banerjee, Normal Mesenteric Lymph Blunts the Pulmonary Inflammatory Response to Endotoxin, Journal of Surgical Research, Volume 136, Issue 2, December 2006, Pages 166-171
A Proteomic Analysis of Human Bile Troels Zakarias et al.Mol Cell Proteomics 2004 3: 715-728 NaMi Cho, Pin-Ju Chueh, Chinpal Kim, Sara Caldwell, Dorothy M. Morré, James D. Morré,(2002)
Monoclonal antibody to a cancer-specific and drug-responsive hydroquinone (NADH) oxidase from the sera of cancer patients. Cancer Immunology, Immunotherapy, Volume 51, Number 3, 121-129 Shapiro, Scott, Beenhouwer, David O., Feldmesser, Marta, Taborda, Carlos, Carroll, Michael C., Casadevall, Arturo, Scharff, Matthew D.
Immunoglobulin G Monoclonal Antibodies to Cryptococcus neoformans Protect Mice Deficient in Complement Component C3 Infect. Immun. 2002 70: 2598-2604
Beenhouwer, David O., Shapiro, Scott, Feldmesser, Marta, Casadevall, Arturo, Scharff, Matthew D.Both Th1 and Th2 Cytokines Affect the Ability of Monoclonal Antibodies To Protect Mice against Cryptococcus neoformans Infect. Immun. 2001 69: 6445-6455
Lucy E. DesJardin Isolation of M. tuberculosis RNA from Sputum Methods in Molecular Medicine™, 2001, Volume 48, Part II., 133-139
Measurement of Sputum Mycobacterium tuberculosis Messenger RNA as a Surrogate for Response to Chemotherapy Am. J. Respir. Crit. Care Med., Volume 160, Number 1, July 1999, 203-210
Gabriel Nussbaum, Wendy Cleare et al, Epitope Location in the Cryptococcus neoformans Capsule Is a Determinant of Antibody Efficacy J. Exp. Med.1997;185:685-694, February 17, 1997
Template Preparation - Production Sequencing Protocols used at the Stanford Genome Technology Center
Increased levels of beta 2 glycoprotein I antigen and beta 2 glycoprotein I binding antibodies are associated with a history of thromboembolic complications in patients with SLE and primary antiphospholipid syndrome. McNally T, Mackie IJ, Machin SJ, et al.Br J Rheumatol. 1995;34:1031–6.
J Krupey - US Patent 5,885,921 Hydrophobic silica adsorbents for lipids
DC Jones - US Patent App. 20,080/287,661 Devices and methods for reducing matrix effects
DJ Morré, NM McCarty, D Morré US Patent 7,053,188, Monoclonal antibodies specific for neoplasia-specific NADH: disulfide reductase.
United States Patent Application 20030170757 Monoclonal antibodies specific for neoplasia-specific NADH: disulfide reductase
